CACNA1D
Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Full Name
Calcium Voltage-Gated Channel Subunit Alpha1 D
Function
Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1D gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines.
Biological Process
Adenylate cyclase-modulating G protein-coupled receptor signaling pathway Source: BHF-UCL
Calcium ion import Source: BHF-UCL
Calcium ion transmembrane transport Source: BHF-UCL
Calcium ion transport Source: UniProtKB
Cardiac muscle cell action potential involved in contraction Source: BHF-UCL
Membrane depolarization during cardiac muscle cell action potential Source: BHF-UCL
Membrane depolarization during SA node cell action potential Source: BHF-UCL
Positive regulation of adenylate cyclase activity Source: UniProtKB
Positive regulation of calcium ion transport Source: BHF-UCL
Regulation of atrial cardiac muscle cell membrane repolarization Source: BHF-UCL
Regulation of heart rate by cardiac conduction Source: BHF-UCL
Regulation of insulin secretion Source: Reactome
Regulation of potassium ion transmembrane transport Source: BHF-UCL
Regulation of potassium ion transmembrane transporter activity Source: BHF-UCL
Sensory perception of sound Source: BHF-UCL
Calcium ion import Source: BHF-UCL
Calcium ion transmembrane transport Source: BHF-UCL
Calcium ion transport Source: UniProtKB
Cardiac muscle cell action potential involved in contraction Source: BHF-UCL
Membrane depolarization during cardiac muscle cell action potential Source: BHF-UCL
Membrane depolarization during SA node cell action potential Source: BHF-UCL
Positive regulation of adenylate cyclase activity Source: UniProtKB
Positive regulation of calcium ion transport Source: BHF-UCL
Regulation of atrial cardiac muscle cell membrane repolarization Source: BHF-UCL
Regulation of heart rate by cardiac conduction Source: BHF-UCL
Regulation of insulin secretion Source: Reactome
Regulation of potassium ion transmembrane transport Source: BHF-UCL
Regulation of potassium ion transmembrane transporter activity Source: BHF-UCL
Sensory perception of sound Source: BHF-UCL
Cellular Location
Membrane
Involvement in disease
Sinoatrial node dysfunction and deafness (SANDD): A disease characterized by congenital severe to profound deafness without vestibular dysfunction, associated with episodic syncope due to intermittent pronounced bradycardia.
Primary aldosteronism, seizures, and neurologic abnormalities (PASNA): A disorder characterized by hypertension, hypokalemia, and high aldosterone levels with low plasma renin activity and an elevated aldosterone/renin ratio. Other features include generalized seizures, cerebral palsy, spasticity, intellectual disability, and developmental delay.
Primary aldosteronism, seizures, and neurologic abnormalities (PASNA): A disorder characterized by hypertension, hypokalemia, and high aldosterone levels with low plasma renin activity and an elevated aldosterone/renin ratio. Other features include generalized seizures, cerebral palsy, spasticity, intellectual disability, and developmental delay.
Topology
Cytoplasmic: 1-126 aa
Helical: 127-145 aa
Extracellular: 146-163 aa
Helical: 164-183 aa
Cytoplasmic: 184-195 aa
Helical: 196-214 aa
Extracellular: 215-235 aa
Helical: 236-254 aa
Cytoplasmic: 255-273 aa
Helical: 274-293 aa
Extracellular: 294-381 aa
Helical: 382-406 aa
Cytoplasmic: 407-523 aa
Helical: 524-543 aa
Extracellular: 544-558 aa
Helical: 559-577 aa
Cytoplasmic: 578-585 aa
Helical: 586-604 aa
Extracellular: 605-614 aa
Helical: 615-633 aa
Cytoplasmic: 634-652 aa
Helical: 653-673 aa
Extracellular: 674-727 aa
Helical: 728-752 aa
Cytoplasmic: 753-886 aa
Helical: 887-905 aa
Extracellular: 906-921 aa
Helical: 922-941 aa
Cytoplasmic: 942-953 aa
Helical: 954-972 aa
Extracellular: 973-978 aa
Helical: 979-998 aa
Cytoplasmic: 999-1017 aa
Helical: 1018-1037 aa
Extracellular: 1038-1127 aa
Helical: 1128-1148 aa
Cytoplasmic: 1149-1205 aa
Helical: 1206-1224 aa
Extracellular: 1225-1239 aa
Helical: 1240-1259 aa
Cytoplasmic: 1260-1266 aa
Helical: 1267-1288 aa
Extracellular: 1289-1313 aa
Helical: 1314-1333 aa
Cytoplasmic: 1334-1352 aa
Helical: 1353-1372 aa
Extracellular: 1373-1439 aa
Helical: 1440-1464 aa
Cytoplasmic: 1465-2161 aa
Helical: 127-145 aa
Extracellular: 146-163 aa
Helical: 164-183 aa
Cytoplasmic: 184-195 aa
Helical: 196-214 aa
Extracellular: 215-235 aa
Helical: 236-254 aa
Cytoplasmic: 255-273 aa
Helical: 274-293 aa
Extracellular: 294-381 aa
Helical: 382-406 aa
Cytoplasmic: 407-523 aa
Helical: 524-543 aa
Extracellular: 544-558 aa
Helical: 559-577 aa
Cytoplasmic: 578-585 aa
Helical: 586-604 aa
Extracellular: 605-614 aa
Helical: 615-633 aa
Cytoplasmic: 634-652 aa
Helical: 653-673 aa
Extracellular: 674-727 aa
Helical: 728-752 aa
Cytoplasmic: 753-886 aa
Helical: 887-905 aa
Extracellular: 906-921 aa
Helical: 922-941 aa
Cytoplasmic: 942-953 aa
Helical: 954-972 aa
Extracellular: 973-978 aa
Helical: 979-998 aa
Cytoplasmic: 999-1017 aa
Helical: 1018-1037 aa
Extracellular: 1038-1127 aa
Helical: 1128-1148 aa
Cytoplasmic: 1149-1205 aa
Helical: 1206-1224 aa
Extracellular: 1225-1239 aa
Helical: 1240-1259 aa
Cytoplasmic: 1260-1266 aa
Helical: 1267-1288 aa
Extracellular: 1289-1313 aa
Helical: 1314-1333 aa
Cytoplasmic: 1334-1352 aa
Helical: 1353-1372 aa
Extracellular: 1373-1439 aa
Helical: 1440-1464 aa
Cytoplasmic: 1465-2161 aa
View more
Anti-CACNA1D antibodies
Products List
+ Filters
Loading...
Target: CACNA1D
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human, Mouse, Rat
Clone: CBFYC-0718
Application*: WB, IP, IF, IH
Target: CACNA1D
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human, Mouse, Rat
Clone: CBYJL-018
Application*: WB, IP, IF, IH
More Infomation
Hot products 
-
Mouse Anti-FTH1 Recombinant Antibody (CBXF-1896) (CBMAB-F3426-CQ)
-
Mouse Anti-ADIPOR2 Recombinant Antibody (V2-179983) (CBMAB-A1369-YC)
-
Rabbit Anti-ADRA1A Recombinant Antibody (V2-12532) (CBMAB-1022-CN)
-
Rabbit Anti-ABL1 (Phosphorylated Y185) Recombinant Antibody (V2-443434) (PTM-CBMAB-0001YC)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-CALR Recombinant Antibody (CBFYC-0763) (CBMAB-C0818-FY)
-
Mouse Anti-CSPG4 Recombinant Antibody (CBFYM-1050) (CBMAB-M1203-FY)
-
Mouse Anti-FN1 Monoclonal Antibody (D6) (CBMAB-1240CQ)
-
Mouse Anti-AP4E1 Recombinant Antibody (32) (CBMAB-A2996-YC)
-
Mouse Anti-FOXA3 Recombinant Antibody (2A9) (CBMAB-0377-YC)
-
Mouse Anti-CD24 Recombinant Antibody (ALB9) (CBMAB-0176CQ)
-
Rat Anti-CD300A Recombinant Antibody (172224) (CBMAB-C0423-LY)
-
Mouse Anti-ACKR3 Recombinant Antibody (V2-261265) (CBMAB-C1023-LY)
-
Mouse Anti-CEMIP Recombinant Antibody (3C12) (CBMAB-K0296-LY)
-
Rat Anti-ABCC11 Recombinant Antibody (V2-179001) (CBMAB-A0236-YC)
-
Mouse Anti-C5b-9 Recombinant Antibody (aE11) (CBMAB-AO138LY)
-
Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)
-
Mouse Anti-B2M Recombinant Antibody (CBYY-0050) (CBMAB-0050-YY)
-
Mouse Anti-GFAP Recombinant Antibody (20) (CBMAB-G2914-LY)
-
Rabbit Anti-Acetyl-Histone H3 (Lys36) Recombinant Antibody (V2-623395) (CBMAB-CP0994-LY)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry



